A/Prof Ramon Varcoe

A/Prof Varcoe is a vascular surgeon at Sydney’s Prince of Wales Hospital where he is director of surgery, anaesthetics and perioperative services for the South Eastern Sydney Local Health District. He is also director of the Prince of Wales operating theatres and of the Vascular Institute, one of Australia’s most prestigious clinical trials centres. His clinical practice focusses on the minimally invasive treatment of aortic conditions, carotid disease and the full gamut of occlusive arterial disease of the lower limb for which he is internationally renowned.

He has a strong academic interest in novel stent and anastomotic technologies, the investigation of intimal hyperplasia, particularly computer flow dynamic modelling and cellular mechanisms, the application of regional foot perfusion mapping following tibial angioplasty and has the first-in-man experience with the Absorb bioresorbable stent technology applied below-the-knee. In 2015, he completed his PhD at the University of New South Wales entitled “The investigation of novel technology and technique in the treatment of vascular disease”. In 2020 he completed a Masters in Clinical Epidemiology focussing on clinical trial design and biostatistics at the University of Sydney.

He is an Associate Professor at the University of New South Wales where he teaches at both undergraduate and postgraduate level. He is founder and course director of the New South Wales Vascular meeting and the VERVE symposium, the largest annual endovascular summit in Australasia.

He is a member of numerous learned societies, has published more than 100 peer reviewed manuscripts, five book chapters, is an invited reviewer for multiple leading journal in the field of vascular medicine, intervention and science, is on the editorial board of the Journal of Endovascular Therapy, Vascular and Endovascular Review, the Journal of Critical Limb Ischemia, the Texas Heart Institute Journal and the Journal of Cardiovascular Surgery and has been invited to speak both nationally and internationally on more than 200 individual occasions.